Mobilat

Mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid, Suprarenal Extract, the active ingredient in Mobilat, is a topical preparation presented as a strength not specified/topical formulation for topical use. It is applied to the skin to address certain dermatological conditions.

GNH USA supplies Mobilat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mobilat is a topical agent used in dermatology to manage inflammatory and keratinisation disorders. - Acne vulgaris: helps reduce inflammatory lesions and comedones. - Psoriasis: may aid in decreasing plaque thickness and scaling. - Seborrheic dermatitis: assists in controlling erythema and flaking. - Minor skin irritations: provides soothing relief and promotes barrier recovery.

Mobilat may cause local reactions typical of topical agents.

Common Side Effects: - Mild erythema: temporary redness at the application site. - Dryness or peeling: due to keratolytic activity. - Tingling sensation: transient feeling of warmth. - Pruritus: mild itching. - Contact dermatitis: irritant or allergic response.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Extensive skin ulceration: prolonged excessive irritation. - Systemic salicylate toxicity: unlikely but possible with large-area use. - Hyperpigmentation: persistent darkening of treated skin. - Secondary infection: bacterial overgrowth in compromised skin.

Before using Mobilat, consider the following safety measures. - Contraindication: avoid use on patients with known hypersensitivity to any component. - Pregnancy: consult a healthcare professional; safety has not been established. - Breastfeeding: use only if advised by a clinician. - Large‑area application: limit to small areas to reduce systemic absorption risk. - Pre‑existing skin conditions: test on a limited area first. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Topical agents can interact with other skin products or systemic medications.

Major Interactions (Avoid): - Concurrent use with other keratolytic or retinoid creams: may increase irritation. - Systemic salicylates (e.g., aspirin) in high doses: potential additive salicylate exposure.

Moderate Interactions (Monitor Closely): - Occlusive dressings: can enhance absorption and irritation. - Antifungal or antibacterial topical agents: may alter efficacy. - Phototherapy: increased photosensitivity risk. - Corticosteroid creams: may mask signs of irritation. - Cosmetic products containing alcohol or fragrance: could exacerbate dryness.